PTH is a key regulator of bone remodeling rate, and the chronic deficiency/absence of this hormone in HypoPT patients causes profound reduction in bone remodeling [3], leading to increased bone mineral density (BMD), changes in bone microarchitecture, and alteration in bone strength. The gene discussed is PTH; the disease is hyperinsulinemic hypoglycemia, familial, 4.